Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers for Major Renal Outcomes in Patients With Diabetes: A 15-Year Cohort Study

PLoS ONE - United States
doi 10.1371/journal.pone.0177654
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Liver Cirrhosis: A Nationwide Cohort Study

Gastroenterology Research and Practice
HepatologyGastroenterology
2019English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin-Converting Enzyme Inhibitors (ACE-Is) Versus Angiotensin- Receptor Blockers (ARBs): Any Superiority?

Journal of Hypertension- Open Access
2012English

A Study on Utilization of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Cardiovascular Diseases

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Comparison of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors for Glycaemic Regulation

Endocrine Abstracts
2014English

Comparative Effectiveness of Angiotensin-Receptor Blockers for Preventing Macrovascular Disease in Patients With Diabetes: A Population-Based Cohort Study

CMAJ
Medicine
2013English

Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Angiotensin-Converting Enzyme 2 and Treatment With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2020English

Updates on the Treatment of Essential Hypertension: A Summary of AHRQ’s Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Direct Renin Inhibitors

Journal of Managed Care Pharmacy
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy